Merck | MRK - Interest Income



Merck reported $109M in Interest Income for its fiscal quarter ending in March of 2025.


Interest Income Change Date
AbbVie USD 73M 19M Mar/2025
Abbott USD 71M 11M Jun/2025
ALKERMES USD 11.09M 949K Jun/2025
AstraZeneca 68M 16M Jun/2025
Biogen USD 32.3M 8.4M Jun/2025
Drreddys Laboratories INR 1.13B 424M Jun/2025
Eli Lilly USD 40M 8.3M Jun/2025
Gilead Sciences 73M 21M Jun/2025
GlaxoSmithKline 50M 4M Jun/2025
Glaxosmithkline 50M 78M Jun/2025
J&J 332M 51M Mar/2025
Medtronic USD 114M 23M Jan/2025
Merck USD 109M 37M Mar/2025
Pacira USD 5.01M 1.89M Jun/2025
Pfizer USD 156M 13M Jun/2025
Prestige Brands 24K 2K Jun/2020
Regeneron Pharmaceuticals 174.8M 1.3M Jun/2025
Roche Holding 2M 12M Dec/2020
Sanofi 76M 10M Jun/2025
Sanofi 76M 77M Jun/2025
United Therapeutics USD 51.3M 200K Jun/2025
Zoetis 19M 4M Jun/2025